Translational Development Acquisition Stock

Translational Development Acquisition Forward P/E

The Forward P/E Ratio of Translational Development Acquisition (TDAC) as of Aug 17, 2026 is 36.19. In the previous year, Forward P/E Ratio was -3,242.38 — a change of -101.12% (higher).

Forward P/E

36.19

YoY

-101.12%

Last updated:

Forward P/E Ratio of Translational Development Acquisition is 2026 36.19 . Forward P/E Ratio of Translational Development Acquisition was 2025 -3,242.38 . It decreases by -101.12% higher compared to the previous year.
Access this data via the Eulerpool API

Translational Development Acquisition Stock analysis

What does Translational Development Acquisition do? Translational Development Acquisition is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Translational Development Acquisition stock

Forward P/E Ratio of Translational Development Acquisition is 36.19 in 2026.

Forward P/E Ratio of Translational Development Acquisition changed from -3,242.38 to 36.19, representing a -101.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Translational Development Acquisition since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Translational Development Acquisition with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Translational Development Acquisition

All Key Metrics — Translational Development Acquisition